Nova announced today that it completed the acquisition of Sentronics Metrology GmbH, a privately held company headquartered in Germany. The transaction is valued at approximately $60 million, paid in ...
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...